Announcements Trials
Browse Landscape

Phase

Phase 3 12Phase 2 9Phase NA 6Phase 1/2 3Phase 1 3Phase 4 2Phase 2/3 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Peripheral Nervous System Diseases 1Pancreatic Neoplasms 1Lymphangioleiomyomatosis 1Breast Neoplasms 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Interventional × Glutamine × Clear all
NCT04634539 2025-08-06

Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer

Cedars-Sinai Medical Center

Phase 1 Completed
18 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04388371 2021-08-11

Glutamine PET Imaging in LAM

Vanderbilt University Medical Center

Phase 1 Completed
5 enrolled

Lymphangioleiomyomatosis

NCT02215083 2017-07-12

L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer

Eastern Regional Medical Center

Phase 1 Withdrawn
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡